CLASS-05 trial: A randomized controlled phase III trial of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy vesus systemic chemotherapy alone for patients with limited peritoneal carcinomatosis of gastric cancer
机构：[1]Nanfang Hosp, Gen Surg, Guangzhou, Guangdong, Peoples R China[2]Southern Med Univ, Nanfang Hosp, Gen Surg, Guangzhou, Guangdong, Peoples R China[3]Peking Univ Canc Hosp, Minimally Invas Gastrointestinal Surg, Beijing, Peoples R China[4]Fudan Univ, Zhongshan Hosp, Gen Surg, Shanghai, Peoples R China[5]Sichuan Univ, West China Hosp, Gen Surg, Chengdu, Sichuan, Peoples R China[6]Fujian Prov Hosp, Gastrointestinal Surg, Fuzhou, Fujian, Peoples R China[7]Sun Yat Sen Univ, Canc Ctr, Gastrointestinal Surg, Guangzhou, Guangdong, Peoples R China中山大学肿瘤防治中心[8]Guangdong Gen Hosp, Gen Surg, Guangzhou, Guangdong, Peoples R China外科科室普通外科广东省人民医院[9]Southern Med Univ, Gen Surg, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China[10]Sun Yat Sen Univ, Affiliated Hosp 3, Gen Surg, Guangzhou, Guangdong, Peoples R China[11]Sun Yat Sen Univ, Affiliated Hosp 6, Colorectal & Annal Surg, Guangzhou, Guangdong, Peoples R China[12]Meizhou Peoples Hosp, Gen Surg, Meizhou, Peoples R China[13]Zhongshan City People Hosp, Gen Surg, Zhongshan, Peoples R China[14]Guangzhou Med Univ, Canc Ctr, Abdominal Surg, Guangzhou, Guangdong, Peoples R China
出处：
ISSN：
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2017]版：
大类|1 区医学
小类|1 区肿瘤学
最新[2023]版：
大类|1 区医学
小类|1 区肿瘤学
第一作者：
第一作者机构：[1]Nanfang Hosp, Gen Surg, Guangzhou, Guangdong, Peoples R China
推荐引用方式(GB/T 7714)：
Liu H.,Li G.,Yu J.,et al.CLASS-05 trial: A randomized controlled phase III trial of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy vesus systemic chemotherapy alone for patients with limited peritoneal carcinomatosis of gastric cancer[J].ANNALS OF ONCOLOGY.2017,28:-.
APA：
Liu, H.,Li, G.,Yu, J.,Su, X.,Sun, Y....&Hu, Y..(2017).CLASS-05 trial: A randomized controlled phase III trial of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy vesus systemic chemotherapy alone for patients with limited peritoneal carcinomatosis of gastric cancer.ANNALS OF ONCOLOGY,28,
MLA：
Liu, H.,et al."CLASS-05 trial: A randomized controlled phase III trial of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy vesus systemic chemotherapy alone for patients with limited peritoneal carcinomatosis of gastric cancer".ANNALS OF ONCOLOGY 28.(2017):-
医学